QQ客服 官方微博 反馈留言

	A Randomized Phase III Clinical Trial of Anlotinib Hydrochloride in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
	Zhao, Yizhuo; Wang, Qiming; Zhang, Li; Shi, Jianhua; Wang, Zhehai; He, Jianxing; Shi, Yuankai; Cheng, Yin; Chen, Weiqiang; Wang, Xiuwen
刊名	JOURNAL OF THORACIC ONCOLOGY
	2017
卷号	12期号:1
关键词	NSCLC Anlotinib multi-targeted tyrosine kinase inhibitor
ISSN号	1556-0864
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3425028
专题	昆明医科大学
推荐引用方式 GB/T 7714	Zhao, Yizhuo,Wang, Qiming,Zhang, Li,et al. A Randomized Phase III Clinical Trial of Anlotinib Hydrochloride in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)[J]. JOURNAL OF THORACIC ONCOLOGY,2017,12(1).
APA	Zhao, Yizhuo.,Wang, Qiming.,Zhang, Li.,Shi, Jianhua.,Wang, Zhehai.,...&Wang, Hongbing.(2017).A Randomized Phase III Clinical Trial of Anlotinib Hydrochloride in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC).JOURNAL OF THORACIC ONCOLOGY,12(1).
MLA	Zhao, Yizhuo,et al."A Randomized Phase III Clinical Trial of Anlotinib Hydrochloride in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)".JOURNAL OF THORACIC ONCOLOGY 12.1(2017).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。